Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
Ras-GRF1
exchange factor molecule contains in addition to the catalytic domain two pleckstrin homology (PH1 and PH2), one IQ and one Dbl homology (DH) domains. In this study we investigated the role of such additional domains. We found that a
Ras-GRF1
mutant lacking PH1 and IQ domains is sufficient to activate c-fos promoter in response to lysophosphatidic acid (LPA). The same mutant did not increase external stimuli-regulated kinase (ERK) activity, suggesting an additional mechanism for the induction of gene transcription. Isolated DH-PH2 module activates
c-Jun
NH(2)-terminal kinase and the c-fos promoter in response to LPA, providing the basis for an ERK-independent mechanism. These results provide evidence that
Ras-GRF1
acts as a bifunctional molecule on both ERK-dependent and independent pathways.
...
PMID:CDC25(Mm)/Ras-GRF1 regulates both Ras and Rac signaling pathways. 1054 64
The
c-Jun
/AP-1 transcription complex is associated with diverse cellular processes such as differentiation, proliferation, transformation, and apoptosis. These different biological endpoints are likely achieved by the regulation of specific target gene expression. We describe the identification of Ras guanine nucleotide exchange factor 1,
Ras-GRF1
, by microarray analysis as a
c-Jun
/AP-1 regulated gene essential for anchorage-independent growth of immortalized rat fibroblasts. Increased
Ras-GRF1
expression, in response to inducible
c-Jun
expression in Rat1a fibroblasts, was confirmed by both real-time PCR and Northern blot analysis. We show that
c-Jun
/AP-1 can bind and activate the
Ras-GRF1
promoter in vivo. A 75-kDa
c-Jun
/AP-1-inducible protein, p75-
Ras-GRF1
, was detected, and the inhibition of its expression with antisense oligomers significantly blocked
c-Jun
-regulated anchorage-independent cell growth. p75-
Ras-GRF1
expression occurred with a concomitant increase in activated Ras (GTP bound), and the activation of Ras was significantly inhibited by antisense
Ras-GRF1
oligomers. Moreover, p75-
Ras-GRF1
could be coprecipitated with a Ras dominant-negative glutathione S-transferase (GST) construct, GST-Ras15A, demonstrating an interaction between p75-
Ras-GRF1
and Ras. A downstream target of Ras activation, Elk-1, had increased transcriptional activity in
c-Jun
-expressing cells, and this activation was inhibited by dominant-negative Ras. In addition,
c-Jun
overexpression resulted in an increase in phospho-AKT while phosphorylation of ERK1/2 remained largely unaffected. The inhibition of phosphatidylinositol 3-kinase (PI3K)-AKT signal transduction by Ly294002 and wortmannin significantly blocked
c-Jun
-regulated morphological transformation, while inhibition of basal MEK-ERK activity with PD98059 and U0126 had little effect. We conclude that
c-Jun
/AP-1 regulates endogenous p75-
Ras-GRF1
expression and that
c-Jun
/AP-1-regulated anchorage-independent cell growth requires activation of Ras-PI3K-AKT signal transduction.
...
PMID:p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. 1579 16